[Abstract] Hepatitis C virus (HCV) can infect naïve cells via entry of "cell-free" extracellular virus or direct "cell-to-cell" transmission. Here, we describe an assay for detecting HCV cell-to-cell transmission, using a non-growing cell culture system that avoids confounding effects of cell 
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3. Continue to incubate cultures at 37 °C in 5% CO2 cell culture incubator to allow time for cell-to-cell spread of HCV to occur (e.g. 48-72 h post-infection).
4. Before proceeding to Section D, collect all the culture medium from the sample wells and transfer it to a new 96-well plate for analysis of neutralization as described in section E below (this can be assayed immediately or stored at -80 °C until assay can be performed).
D. Visualizing HCV cell-to-cell spread via immunostaining
Under these conditions, multicellular HCV foci can only be formed by cell-to-cell spread.
Hence, the number of HCV-positive cells in individual HCV foci can be used as a readout for cell-to-cell transmission. Here immunostaining is described to visualizing HCV infected cells, but other methods can be used (e.g. Supplemental protocol A).
Copyright © 2014 The Authors; exclusive licensee Bio-protocol LLC. 13. Quantify and photograph foci using an appropriate microscope. The number of HCVpositive cells per foci is a read-out of HCV cell-to-cell spread (see Figure 1 ).
E. Neutralization control assay
To ensure that cell-free virus in the medium is neutralized during the assay, the presence of infectious cell-free virus in the medium of experimental cultures should be assayed. These samples are harvested at the end of the spread assay as described in section C4). b. Incubate the plate at 37 °C in 5% CO2 cell culture incubator overnight.
2. Aspirate out plating media and transfer the media samples (~200 µl) onto naïve Huh7 cell monolayers.
3. At 24h aspirate off viral inoculum and add 200 µl/well fresh 10% FBS cDMEM.
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At 72 h post-inoculation, fix the cells and perform immunostaining to detect HCV-infected cells (as above).
If infectious virus is detected in the supernatants, cell-to-cell spread cannot be accurately determined from the assay.
F. Assess the effect of different factors on HCV cell-to-cell spread
Aside from monitoring the kinetics of HCV cell-to-cell spread, this assay can be used to identify cellular factors involved in or antivirals that inhibit this step of the viral lifecycle.
1. Use of Inhibitors.
Inhibitors to specific factors or antivirals with unknown mechanisms of action can be added when cell-free virus entry is blocked at step C2. In this case, appropriate controls should also be included as well:
a. "Mock" treated negative control samples (e.g. diluent or IgG control) should be included to control for non-specific inhibition.
b. As a positive control for inhibition of cell-to-cell spread, parallel cultures can be treated with an inhibitor that blocks a factor known to be required for HCV cell-to-cell spread (e.g. 20 µg/ml anti-Claudin antibody, 30 µg/ml anti-NPC1L1 antibody or 30 µM of the NPC1L1 inhibitor, Ezetimibe). In the absence of cell division the foci formed in the presence of these HCV spread inhibitors are limited to 1-2 cells.
Note: When performing this assay in actively dividing cells (Supplemental protocol B), these controls are particularly helpful in determining the number of cell divisions that occurred during the assay, i.e. the size of the foci in these control samples provide an indication of the extent to which cell division may have contributed to in increased foci
size.
siRNA knockdown.
RNAi is an alternative method for assessing the involvement of cellular genes in HCV cell-to-cell spread. In this case, the assay is carried out as described above after silencing the gene of interest (see Supplemental protocol C). In this case, the following controls should be included:
a. To monitor and control for non-specific effects of the transfection.
i. Untreated and mock transfected control samples.
ii. Non-specific siRNA transfected control samples (e.g. siScramble or siGFP).
b. As a positive control for inhibition of cell-to-cell spread parallel cultures can be transfected with siRNA targeting a factor known to be required for HCV cell-to-cell spread (e.g. Claudin 1 or NPC1L1).
c. During the spread assay, the expression level of the siRNA-targeted gene should be monitored in parallel samples (e.g. RT-qPCR and/or western blot, and/or functional assays, if available).
Although not described here, this silencing approach requires initial experiments to determine the efficiency and kinetics of specific gene silencing to ensure the assay is performed under optimal silencing conditions. Also, because factors of interest may be involved in cell-free extracellular virus entry, virus inoculation should be performed before the silencing takes effect so that the first round of infection can occur.
Note: If silencing begins prior to infection initiation partial inhibition of infection may result in reduced numbers of foci being formed, however the readout for cell-to-cell spread is foci size not foci number thus this technical issue should not prevent analysis of cell-tocell spread unless the initial infection is blocked completely.

G. Example results and Interpretation
When cell-to-cell spread is blocked, foci of only 1-2 cells in size are observed. Hence, in non- For each well of a 96-well plate to be transfected:
i. Mix 0.84 µl 10 µM siRNA stock with 30 µl OptiMEM.
ii. Add 1.2 µl RNAiMax to the siRNA-OptiMEM and gently mix.
iii. Incubate at RT for 20 min. f. Incubate at 37 °C in 5% CO2 cell culture incubator overnight.
g. Proceed with infection as described in the Main protocol step B2 (if the silenced gene may be required for cell-free extracellular virus entry, it is recommended to infect the cultures 20-24 h post-transfection before the targeted gene is efficiently silenced).
Notes
In each user's hands it is important to determine the number of infectious units and time of incubation that will result in the formation of a sufficient number of well-separated foci, which are big enough to clearly observe spread. This can be achieved by performing pilot assays with different volumes of virus inoculum and incubating for various periods of time.
